Phase 3
N=471
Stimulant Abuser Groups to Engage in 12-Step
Drug Abuse
Bottom Line
View on ClinicalTrials.gov: NCT00573183 ↗Enrolled (actual)
471
Serious AEs
11.0%
Results posted
Jan 2014
Primary outcome: Primary: Days of Stimulant Use — 2.35; 2.13 days of stimulant use — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- STAGE-12 (Behavioral); Treatment as Usual (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Apr 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Days of Stimulant Use |
2.35; 2.13 | <0.05 sig |
| SECONDARY Attendance at 12-step Meetings |
12.01; 10.52 | <0.05 sig |
Summary
The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.
Eligibility Criteria
Inclusion Criteria
- seeking outpatient treatment for stimulant abuse or dependence
- current diagnosis of stimulant abuse or dependence
- willing to participate in the protocol
Exclusion Criteria
- not sufficiently medically or psychiatrically stable
- pending legal action that would inhibit their participation in the study
- in need of detoxification from opiates
Data sourced from ClinicalTrials.gov (NCT00573183). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.